A5030634220- Frailty in Older Adults
- Cancer survivorship and care
- Head and Neck Cancer Studies
- Nutrition and Health in Aging
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Practices and Patient Outcomes
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Research Studies
- Palliative Care and End-of-Life Issues
- Cardiac, Anesthesia and Surgical Outcomes
- Advances in Oncology and Radiotherapy
- Pharmaceutical studies and practices
- Inflammatory Biomarkers in Disease Prognosis
- Head and Neck Surgical Oncology
- Oral health in cancer treatment
- Vascular Tumors and Angiosarcomas
- Acute Myeloid Leukemia Research
- Cutaneous Melanoma Detection and Management
- Bladder and Urothelial Cancer Treatments
- Cancer-related cognitive impairment studies
- Management of metastatic bone disease
- Cancer Genomics and Diagnostics
- Economic and Financial Impacts of Cancer
Ann Arbor Center for Independent Living
2023
University of Rochester Medical Center
2016-2022
University of Rochester
2016-2021
Oregon Health & Science University
2014-2020
American Society of Clinical Oncology
2020
University of Florida
2020
National Cancer Centre Singapore
2018
Hospital Universitario Fundación Jiménez Díaz
2018
VA Portland Health Care System
2017
Beth Israel Deaconess Medical Center
2017
For patients with cancer who are older than 65 years, the 2018 ASCO Guideline recommends geriatric assessment (GA) be performed. However, there limited data on providers' practices using GA. Therefore, ASCO's Geriatric Oncology Task Force conducted a survey of providers to assess practice patterns and barriers
To evaluate the prevalence of polypharmacy and potentially inappropriate medication (PIM) use association between these chemotherapy-related adverse events in older adults with cancer undergoing chemotherapy.Secondary analysis prospectively collected data.Outpatient oncology clinics seven academic medical centers.Adults aged 65 chemotherapy.Measures included number daily medications (polypharmacy); PIM based on three indices (Beers, Zhan, Drugs to Avoid Elderly criteria), six "high risk"...
To evaluate the efficacy and toxicity of immune checkpoint inhibitors (ICIs) in older patients with advanced non-small cell lung cancer (NSCLC) seen routine clinical practice.Retrospective study.Single academic institution its affiliated centers.Patients 70 years or advanced-stage NSCLC between April 1, 2015, 2017, treated ICIs.Efficacy data included overall survival (OS) time to treatment failure (TTF), stratified by age, comorbidities (Charlson Comorbidity Index [CCI]), Eastern Cooperative...
In January 2020, the World Health Organization (WHO) declared 2019 coronavirus disease (COVID-19) a public health emergency of international concern [[1]Organization WH Responding to community spread COVID-19: interim guidance, 7 March 2020. Organization, 2020Google Scholar]. response, WHO called for implementation risk communication and engagement help support efforts combat epidemic wake emergence this novel virus, 80% deaths reported in U.S. have been adults aged 65 years older...
Frailty is associated with an increased risk of chemotherapy toxicity. Cellular markers inflammation can help identify patients frailty characteristics. However, the role cellular in identifying at developing chemotherapy-induced and their clinical utility are not fully understood.This study was a secondary analysis large nationwide cohort women stage I-IIIC breast cancer (n = 581, mean age 53.4; range 22-81). Measures were completed pre-chemotherapy (T1), post-chemotherapy (T2), 6 months...
Older adults compose the majority of patients with cancer in United States; however, it is unclear how well geriatrics or geriatric oncology training being incorporated into hematology-oncology (hem-onc) fellowships.A convenience sample hem-onc fellows completed a (written electronic) survey assessing their education, clinical experiences, and perceived proficiency during training; knowledge base oncology; confidence managing older cancer; general attitudes toward principles.Forty-five...
Trimodality therapy for resectable esophageal and gastroesophageal junction cancers utilizing preoperative radiotherapy with concurrent carboplatin paclitaxel-based chemotherapy is being increasingly utilized secondary to the results of phase III CROSS trial. However, there a paucity reports this regimen as component chemoradiotherapy in North America. We aim report on our clinical experience using modified higher doses. Patients advanced (cT2-cT4 or node positive) carcinoma who received...
Abstract BACKGROUND: Little is known about complementary medication use among older adults with cancer, particularly those who are receiving chemotherapy. The objective of this study was to evaluate the prevalence and identify factors associated its cancer. METHODS: (defined as herbal agents, minerals, or other dietary supplements, excluding vitamins) evaluated in a cohort aged ≥65 years were start chemotherapy for their associations between patient characteristics (sociodemographics;...
Abstract Background Treatment of head and neck cancer is complex, a multidisciplinary clinic may improve the coordination care. The value has not yet been established in oropharyngeal squamous cell carcinoma (SCC). Methods A retrospective review was conducted Veterans Affairs patients with SCC undergoing concurrent chemoradiation before after implementation clinic. Results Fifty‐two 54 were included this study. Age, tobacco use, p16+ status similar between groups. With clinic, time to...
Integrating audiological management into the care pathways of clinical specialties that prescribe ototoxic medications for essential, often life-preserving medical is critical early hearing loss identification and remediation. Research shows successful implementation a new health service or intervention requires alignment goals among provider groups, institutional leadership patients. Thoughtful consideration physician's viewpoints about ototoxicity its implications treatment planning is,...